Research design considerations for single-dose analgesic clinical trials in acute pain

IMMPACT recommendations

Stephen A. Cooper, Paul J. Desjardins, Dennis C. Turk, Robert H. Dworkin, Nathaniel P. Katz, Henrik Kehlet, Jane C. Ballantyne, Laurie B. Burke, Eugene Carragee, Penney Cowan, Scott Croll, Raymond A. Dionne, John T. Farrar, Ian Gilron, Debra B. Gordon, Smriti Iyengar, Gary W. Jay, Eija A. Kalso, Robert D. Kerns, Michael P. Mcdermott & 12 others Srinivasa Naga Raja, Bob A. Rappaport, Christine Rauschkolb, Mike A. Royal, Märta Segerdahl, Joseph W. Stauffer, Knox H. Todd, Geertrui F. Vanhove, Mark S. Wallace, Christine West, Richard E. White, Christopher Wu

Research output: Contribution to journalArticle

Abstract

This article summarizes the results of a meeting convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) on key considerations and best practices governing the design of acute pain clinical trials. We discuss the role of early phase clinical trials, including pharmacokinetic-pharmacodynamic (PK-PD) trials, and the value of including both placebo and active standards of comparison in acute pain trials. This article focuses on single-dose and short-duration trials with emphasis on the perioperative and study design factors that influence assay sensitivity. Recommendations are presented on assessment measures, study designs, and operational factors. Although most of the methodological advances have come from studies of postoperative pain after dental impaction, bunionectomy, and other surgeries, the design considerations discussed are applicable to many other acute pain studies conducted in different settings.

Original languageEnglish (US)
Pages (from-to)288-301
Number of pages14
JournalPain
Volume157
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Acute Pain
Pain Measurement
Analgesics
Research Design
Clinical Trials
Postoperative Pain
Practice Guidelines
Tooth
Pharmacokinetics
Placebos

Keywords

  • Acute pain
  • Assay sensitivity
  • Clinical trial methods
  • Proof-of-concept trials
  • Randomized clinical trials
  • Research design

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Neurology
  • Pharmacology

Cite this

Cooper, S. A., Desjardins, P. J., Turk, D. C., Dworkin, R. H., Katz, N. P., Kehlet, H., ... Wu, C. (2016). Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain, 157(2), 288-301. https://doi.org/10.1097/j.pain.0000000000000375

Research design considerations for single-dose analgesic clinical trials in acute pain : IMMPACT recommendations. / Cooper, Stephen A.; Desjardins, Paul J.; Turk, Dennis C.; Dworkin, Robert H.; Katz, Nathaniel P.; Kehlet, Henrik; Ballantyne, Jane C.; Burke, Laurie B.; Carragee, Eugene; Cowan, Penney; Croll, Scott; Dionne, Raymond A.; Farrar, John T.; Gilron, Ian; Gordon, Debra B.; Iyengar, Smriti; Jay, Gary W.; Kalso, Eija A.; Kerns, Robert D.; Mcdermott, Michael P.; Raja, Srinivasa Naga; Rappaport, Bob A.; Rauschkolb, Christine; Royal, Mike A.; Segerdahl, Märta; Stauffer, Joseph W.; Todd, Knox H.; Vanhove, Geertrui F.; Wallace, Mark S.; West, Christine; White, Richard E.; Wu, Christopher.

In: Pain, Vol. 157, No. 2, 01.02.2016, p. 288-301.

Research output: Contribution to journalArticle

Cooper, SA, Desjardins, PJ, Turk, DC, Dworkin, RH, Katz, NP, Kehlet, H, Ballantyne, JC, Burke, LB, Carragee, E, Cowan, P, Croll, S, Dionne, RA, Farrar, JT, Gilron, I, Gordon, DB, Iyengar, S, Jay, GW, Kalso, EA, Kerns, RD, Mcdermott, MP, Raja, SN, Rappaport, BA, Rauschkolb, C, Royal, MA, Segerdahl, M, Stauffer, JW, Todd, KH, Vanhove, GF, Wallace, MS, West, C, White, RE & Wu, C 2016, 'Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations', Pain, vol. 157, no. 2, pp. 288-301. https://doi.org/10.1097/j.pain.0000000000000375
Cooper, Stephen A. ; Desjardins, Paul J. ; Turk, Dennis C. ; Dworkin, Robert H. ; Katz, Nathaniel P. ; Kehlet, Henrik ; Ballantyne, Jane C. ; Burke, Laurie B. ; Carragee, Eugene ; Cowan, Penney ; Croll, Scott ; Dionne, Raymond A. ; Farrar, John T. ; Gilron, Ian ; Gordon, Debra B. ; Iyengar, Smriti ; Jay, Gary W. ; Kalso, Eija A. ; Kerns, Robert D. ; Mcdermott, Michael P. ; Raja, Srinivasa Naga ; Rappaport, Bob A. ; Rauschkolb, Christine ; Royal, Mike A. ; Segerdahl, Märta ; Stauffer, Joseph W. ; Todd, Knox H. ; Vanhove, Geertrui F. ; Wallace, Mark S. ; West, Christine ; White, Richard E. ; Wu, Christopher. / Research design considerations for single-dose analgesic clinical trials in acute pain : IMMPACT recommendations. In: Pain. 2016 ; Vol. 157, No. 2. pp. 288-301.
@article{07c723f7e9e042e2a0ce6093abb56f31,
title = "Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations",
abstract = "This article summarizes the results of a meeting convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) on key considerations and best practices governing the design of acute pain clinical trials. We discuss the role of early phase clinical trials, including pharmacokinetic-pharmacodynamic (PK-PD) trials, and the value of including both placebo and active standards of comparison in acute pain trials. This article focuses on single-dose and short-duration trials with emphasis on the perioperative and study design factors that influence assay sensitivity. Recommendations are presented on assessment measures, study designs, and operational factors. Although most of the methodological advances have come from studies of postoperative pain after dental impaction, bunionectomy, and other surgeries, the design considerations discussed are applicable to many other acute pain studies conducted in different settings.",
keywords = "Acute pain, Assay sensitivity, Clinical trial methods, Proof-of-concept trials, Randomized clinical trials, Research design",
author = "Cooper, {Stephen A.} and Desjardins, {Paul J.} and Turk, {Dennis C.} and Dworkin, {Robert H.} and Katz, {Nathaniel P.} and Henrik Kehlet and Ballantyne, {Jane C.} and Burke, {Laurie B.} and Eugene Carragee and Penney Cowan and Scott Croll and Dionne, {Raymond A.} and Farrar, {John T.} and Ian Gilron and Gordon, {Debra B.} and Smriti Iyengar and Jay, {Gary W.} and Kalso, {Eija A.} and Kerns, {Robert D.} and Mcdermott, {Michael P.} and Raja, {Srinivasa Naga} and Rappaport, {Bob A.} and Christine Rauschkolb and Royal, {Mike A.} and M{\"a}rta Segerdahl and Stauffer, {Joseph W.} and Todd, {Knox H.} and Vanhove, {Geertrui F.} and Wallace, {Mark S.} and Christine West and White, {Richard E.} and Christopher Wu",
year = "2016",
month = "2",
day = "1",
doi = "10.1097/j.pain.0000000000000375",
language = "English (US)",
volume = "157",
pages = "288--301",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Research design considerations for single-dose analgesic clinical trials in acute pain

T2 - IMMPACT recommendations

AU - Cooper, Stephen A.

AU - Desjardins, Paul J.

AU - Turk, Dennis C.

AU - Dworkin, Robert H.

AU - Katz, Nathaniel P.

AU - Kehlet, Henrik

AU - Ballantyne, Jane C.

AU - Burke, Laurie B.

AU - Carragee, Eugene

AU - Cowan, Penney

AU - Croll, Scott

AU - Dionne, Raymond A.

AU - Farrar, John T.

AU - Gilron, Ian

AU - Gordon, Debra B.

AU - Iyengar, Smriti

AU - Jay, Gary W.

AU - Kalso, Eija A.

AU - Kerns, Robert D.

AU - Mcdermott, Michael P.

AU - Raja, Srinivasa Naga

AU - Rappaport, Bob A.

AU - Rauschkolb, Christine

AU - Royal, Mike A.

AU - Segerdahl, Märta

AU - Stauffer, Joseph W.

AU - Todd, Knox H.

AU - Vanhove, Geertrui F.

AU - Wallace, Mark S.

AU - West, Christine

AU - White, Richard E.

AU - Wu, Christopher

PY - 2016/2/1

Y1 - 2016/2/1

N2 - This article summarizes the results of a meeting convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) on key considerations and best practices governing the design of acute pain clinical trials. We discuss the role of early phase clinical trials, including pharmacokinetic-pharmacodynamic (PK-PD) trials, and the value of including both placebo and active standards of comparison in acute pain trials. This article focuses on single-dose and short-duration trials with emphasis on the perioperative and study design factors that influence assay sensitivity. Recommendations are presented on assessment measures, study designs, and operational factors. Although most of the methodological advances have come from studies of postoperative pain after dental impaction, bunionectomy, and other surgeries, the design considerations discussed are applicable to many other acute pain studies conducted in different settings.

AB - This article summarizes the results of a meeting convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) on key considerations and best practices governing the design of acute pain clinical trials. We discuss the role of early phase clinical trials, including pharmacokinetic-pharmacodynamic (PK-PD) trials, and the value of including both placebo and active standards of comparison in acute pain trials. This article focuses on single-dose and short-duration trials with emphasis on the perioperative and study design factors that influence assay sensitivity. Recommendations are presented on assessment measures, study designs, and operational factors. Although most of the methodological advances have come from studies of postoperative pain after dental impaction, bunionectomy, and other surgeries, the design considerations discussed are applicable to many other acute pain studies conducted in different settings.

KW - Acute pain

KW - Assay sensitivity

KW - Clinical trial methods

KW - Proof-of-concept trials

KW - Randomized clinical trials

KW - Research design

UR - http://www.scopus.com/inward/record.url?scp=84955621171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955621171&partnerID=8YFLogxK

U2 - 10.1097/j.pain.0000000000000375

DO - 10.1097/j.pain.0000000000000375

M3 - Article

VL - 157

SP - 288

EP - 301

JO - Pain

JF - Pain

SN - 0304-3959

IS - 2

ER -